Hyperfine (HYPR) Times Interest Earned (2021 - 2026)

Hyperfine (HYPR) posted Times Interest Earned of -$103.11 for Q1 2026, down 666.46% on a QoQ basis from -$13.45 in Q4 2025.

Hyperfine (HYPR) Times Interest Earned (2021 - 2026) Analysis & Trends

Hyperfine's Times Interest Earned history runs 6 years deep, the most recent figure standing at -$103.11 for Q1 2026.

Quarterly Times Interest Earned changed N/A year-over-year to -$103.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$418.57 (changed N/A YoY) and the FY2025 annual result came in at -$65.06, up 61.47% from the prior year.
Times Interest Earned was -$103.11 for Q1 2026 at Hyperfine, down from -$13.45 in the prior quarter.
Across five years, Times Interest Earned topped out at -$6.59 in Q4 2023 and bottomed at -$221.88 in Q1 2024.
A 5-year average of -$100.48 and a median of -$94.96 in 2022 frame the typical range for Times Interest Earned.
Annual changes were most pronounced in 2022 — Times Interest Earned slumped 9900.31% — and 2023, when it jumped 92.41%.
Hyperfine's Times Interest Earned stood at -$86.81 in 2022, then soared by 92.41% to -$6.59 in 2023, then tumbled by 537.87% to -$42.05 in 2024, then surged by 68.01% to -$13.45 in 2025, then tumbled by 666.46% to -$103.11 in 2026.
Business Quant data shows HYPR's Times Interest Earned at -$103.11 in Q1 2026, -$13.45 in Q4 2025, and -$42.05 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.90
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	6.32
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	13.19
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	2.15
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	1.19
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	82.35
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-2.90
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	5.36
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Hyperfine	92.81 Mn	51.53 Mn	1.98 Mn	-103.11

Download Data